Strategic Integration of Emerging Technologies for Large-scale Problems in need of Innovative Strategic Solutions. Stem Tech is a rollup of several long-standing global technology and strategic solutions companies that have come together under a common approach to benefit the world by advancing emerging technologies into strategic solutions. As of December 2024: 13 Matrix C/V/D-Suite experts, scientists, and engineers; 60+ applicants for matrix team; 2 patent/IP acquisitions; 20+ IP companies/IPs/Patents submitted for consideration to joining Stem Tech.

Holding company for global R&D through operating companies in healthcare, public health, industrial medicine, scientific/medical R&D. Implemented global consolidation and rollout strategy.

Strategic Industry Leader in a decentralized Web3 metaverse platform. The next generation of immersive technology leveraging the opportunities in accelerated education, workplace, healthcare, entertainment, training, information, and corporate strategic relationships. www.Meta-Cities.com

Consultant to C-Suite for over 400 medium-large, public, and government entities. Business Development partnerships/joint ventures/consulting in emerging technologies and integration into global markets. Leveraging exclusive advantages of scientific evidence, new advanced technologies, and emerging opportunities.* Consultant for a public company (NASDAQ and an established industry leader) threatened with delisting from NASDAQ. Within 1 week, created a strategic plan that raised $32 million within 30 days, and boosted the stock value from $0.60 to $16.00.* Consultant for a client company expanding into global biotech. Created a new product line's strategic plan, brand, and secure supply chain. The company was acquired by a public company and remains a client for over 15 years.

Leveraging emerging technologies in DNA Polymerases and biotechnologies for use in the biotech industry. Corporate strategy for client companies (institutions, universities, government labs, public companies, and private biotech companies) to take advantage of the new competitive edge provided by these new technologies.*Created international product line for client company - bought by public company.*Created strategic plan for a public biotech leader (NASDAQ) to raise $32m within 30 days and boost stock value from $0.60 to $16.00. Eventually bought by LabCorp.

* Specialized in scalable businesses: Healthcare, Biotech, Emerging Technologies, Engineering, Global business, Corporate Strategy, Global Corporate Alliances, and M&A.* Consultant for over 550 SBDC/UNR and 400 private client companies - Raised over $30 million of capital the first year (2020-2021), provide strategic plans that converted a $3MM company valuation into $70MM, a $14MM Series A into a $42MM Series B and valuation from $40MM to $210MM with secondary LBO, and employee/shareholder-friendly M&A to build a $1MM company into a $50MM investment-based valuation.* Consultant for companies ranging from start-up through 30 years of operations, and phases covering technology post-feasibility study through global corporate strategy, joint ventures, capitalization (Series A - C), and M&A.

2yrs. Manager-Professional Ski Patrol/6yrs. On-Call Response Team: Reorganized staffing and structure, standardized procedures, restructured training and certification, decentralized operations, and upgraded Professional Patrol capabilities to include avalanche control and rescue, FEMA incident management, inter-agency coordination, risk management, and operational efficiency, transparency, and accountability.

Research, Development, and implementation of a breakthrough technology in High-Intensity UVB-C LED elimination of known pathogens (viruses, bacteria, and mold spores) at new UV levels that are magnitudes greater than previously possible levels to make it commercially viable for public spaces, transportation industries, healthcare, government/military defense, and national security. Initiated M&A to grow valuation from $1MM to $50MM.

Emerging technologies in spine care research, treatment protocols, technologies, and clinic integration to help medical professionals (MD, DO, PT, OT, MS) provide the best outcomes, accountability, and cost effective care for patients, employers, and payers. Part of DBC network with 160 scientific publications in peer-reviewed journals, 29 RTCs, and over 92% success rates in ongoing Clinical Trials with over 200,000 patients in over 24 countries, and 120+ clinics.

Medical Billing Company: 75% over industry standard in insurance reimbursement due to evidence-based approach, outcome-based reimbursement, and exclusive carveouts. Medical Practice Management company for evidence-based, outcome-justified, orthopedic, neurosurgery, interventional pain management, and industrial medicine practices. Genesis Systems: Developed the Anti-G Loss of Consciousness (G-LOC) Training Program for the US Air Force Tactical Air Command (TAC) based on outcome-based measures and metrics. Required certification for each fighter pilot and established standardized G-LOC Certification and Training Centers in every TAC base. Later used by US Naval Air Force. Developed the Industrial Medicine Corp-Fit Mission Specific Training and Readiness Program and School for the 1st Cavalry Division (13,000 personnel) and III Corps (34,000 personnel) with unprecedented objective outcomes: Increased expertise life cycle; 100% increase in re-enlistment; 100% reduction in Crime in the Barracks; 100% pass rate in Physical Aptitude tests; 100% increase in Inspector General Inspections; 100% increase in promotions, awards, and certificates of accomplishment; drastic increase in the Unit Climate Survey (work satisfaction).

U.S. Subsidiary of David Fitness and Medical, OY., Finland. Joined as Director of a company that was generating $1.5M in revenue but $1.78M in losses, became VP then President to become profitable within 18 months. Bought the company.